Abacus Medicine A/S

Public limited companyCVR 28111576København VActive

Abacus Medicine A/S is a public limited company, based in København V, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2004. Net profit fell 56% from 2024 to 2025, ending at DKK 7.8m. With 388 employees, the company is about 43 times larger than the industry median. Gross profit is higher than that of 96% of the companies in the industry in the database.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 1.8bn+22.2% vs. 2024
Net profitDKK 7.8m−55.9% vs. 2024
EquityDKK 98.5m+2.7% vs. 2024
Employees388latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Revenue rose 22% (2024 → 2025), to DKK 1.8bn.
  • Net profit fell 56% (2024 → 2025), to DKK 7.8m.
  • Equity rose 3% (2024 → 2025), to DKK 98.5m.

Employees

  • 19 more employees than a year earlier: 388 (07/2026) against 369 (07/2025).

Registrations, last 24 months

  • 31/05/2026: Share capital changed from 518,822 DKK to 522,646 DKK
  • 05/05/2025: Share capital changed from 516,201 DKK to 518,822 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2019–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 20mDKK 40mDKK 60mDKK 80mDKK 100m2019202020212022202320242025
EquityNet profit
Financial figures for Abacus Medicine A/S
2019202020212022202320242025Change
Revenue421,445663,501940,7401,023,9781,210,3541,486,9641,817,637+22.2%
Gross profit––––––196,919–
Operating profit (EBIT)–5,3476,40414,72435,56637,49427,617−26.3%
Profit before tax2,5771,3372,0638,51025,68621,50912,214−43.2%
Net profit8294334155,81920,04217,6217,779−55.9%
Total assets126,964219,527215,576232,976318,940357,304494,720+38.5%
Equity51,61653,02454,64660,99180,86695,89598,523+2.7%
Liabilities75,348166,503160,930171,985238,074261,409396,197+51.6%
Cash and cash equivalents1,9752183,8899,9713,2689,99215,965+59.8%
Average number of employees6189121,0522072410––

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 5mDKK 10mDKK 15mDKK 20m2019202020212022202320242025
Net profitMedian, the industry (232 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

7 financial years
Annual reports for Abacus Medicine A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202530/03/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202427/03/2025The companyPDFXBRL
202301/01/2023 – 31/12/202303/04/2024The companyPDFXBRL
202201/01/2022 – 31/12/202229/03/2023The companyPDFXBRL
202101/01/2021 – 31/12/202119/04/2022The companyPDFXBRL
202001/01/2020 – 31/12/202002/07/2021The companyPDFXBRL
201901/01/2019 – 31/12/201931/08/2020The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
010020030040008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

232 companies in the database

Comparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.

Gross profitDKK 196.9mNo. 11 of 232
Better than 96% of the companies in the industry
EquityDKK 98.5mNo. 25 of 232
Better than 90% of the companies in the industry
Number of employees388No. 8 of 232
Better than 97% of the companies in the industry

Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.

DKK 100kDKK 1.4mDKK 19.1mDKK 263.2mDKK 1.5bnHere
Distribution of gross profit for 225 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 200–499 employees796 companies in the comparison
No. 296of 763
Better than 61%
No. 401of 796
Better than 50%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 338of 24,791
Better than 99%
No. 1,378of 24,909
Better than 94%
All companies of type A/S18,025 companies in the comparison
No. 803of 17,786
Better than 95%
No. 2,294of 18,024
Better than 87%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of pharmaceutical goods and nursing supplies
Gross profit
  1. Abacus Medicine A/SDKK 196.9m
  2. Ambu A/SDKK 3.6bn
  3. Stada Nordic ApSDKK 687m
Net profit
  1. Abacus Medicine A/SDKK 7.8m
  2. Ambu A/SDKK 609m
  3. Stada Nordic ApSDKK 54.6m
Equity
  1. Abacus Medicine A/SDKK 98.5m
  2. Ambu A/SDKK 6bn
  3. Stada Nordic ApSDKK 346.3m
Employees
  1. Abacus Medicine A/S388
  2. Ambu A/S619
  3. Stada Nordic ApS51

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Abacus Medicine A/S

Management

8 active registrations

Executive management

Executive management at Abacus Medicine A/S
NameRoleAppointed
Flemming WagnerCEO10/02/2009

Board of directors

Board of directors at Abacus Medicine A/S
NameRoleAppointed
Flemming WagnerBoard member10/02/2009
Mark JohnstonBoard member16/09/2019
Anders Kunze BøndingBoard member16/09/2019
Troels Peter TroelsenBoard member26/08/2020
Jens Albert HarsaaeChair of the board15/03/2024
Sharon Evelyn CurranBoard member04/10/2024
Alette Margaretha VerbeekBoard member04/10/2024
Founders
Wagner Family Holding ApS, Per Villendrup Jenster
Former management (16)
Former management at Abacus Medicine A/S
NameRoleAppointedResigned
Per Villendrup JensterChair of the board17/09/200418/01/2012
John WagnerBoard member17/09/200415/05/2017
John WagnerDirector17/09/200410/02/2009
Jytte Birgitte WagnerBoard member17/09/200410/02/2009
Lars Christian BruhnChair of the board18/01/201228/08/2013
Lars AaenBoard member31/05/201301/09/2014
Troels Peter TroelsenChair of the board28/08/201325/08/2020
Iwan AlstrupBoard member01/09/201415/05/2017
Ole JensenBoard member08/10/201426/08/2020
Jens Albert HarsaaeBoard member15/05/201720/09/2018
Bo Michael PalmBoard member15/05/201702/10/2017
Jens Albert HarsaaeDeputy chair21/09/201815/09/2019
Anders Kunze BøndingDeputy chair02/05/201915/09/2019
Jens Albert HarsaaeBoard member16/09/201914/03/2024
Niels SmedegaardChair of the board26/08/202015/03/2024
Michala Fischer-HansenBoard member29/09/202115/03/2024

Signing rule: Selskabet tegnes af et medlem af direktionen i forening med bestyrelsens formand, af den administrerende direktør i forening med et medlem af direktionen, af et medlem af direktionen i forening med to medlemmer af bestyrelsen eller af den samlede bestyrelse.

Address and production units

1 active production units

Kalvebod Brygge 35
1560 København V

København Municipality · Postcode 1560

Open in OpenStreetMap
Production units
Production unitAddressEmployeesP number
ABACUS MEDICINE A/SKalvebod Brygge 35, 1560 København V3911010774299

Purpose

Selskabets formål er at drive parallelhandel med lægemidler, handel med medicin vedrørende ikke-registrerede lægemidler og handel med lægemidler i forbindelse med kliniske forsøg samt hermed beslægtet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

78 registered events
20262 changescapital 1 · accounts 1
  • Share capital changed from 518,822 DKK to 522,646 DKK
  • Annual report for 2025 published
20252 changescapital 1 · accounts 1
  • Share capital changed from 516,201 DKK to 518,822 DKK
  • Annual report for 2024 published
20247 changesmanagement 6 · accounts 1
  • Alette Margaretha Verbeek appointed board member
  • Sharon Evelyn Curran appointed board member
  • Annual report for 2023 published
  • Jens Albert Harsaae appointed chair of the board
  • Michala Fischer-Hansen stepped down as board member
  • Niels Smedegaard stepped down as chair of the board
  • Jens Albert Harsaae stepped down as board member
20231 changeaccounts 1
  • Annual report for 2022 published
20222 changesaccounts 1 · capital 1
  • Annual report for 2021 published
  • Share capital changed from 515,033 DKK to 516,201 DKK
20215 changesmanagement 1 · address 1 · capital 2 · accounts 1
  • Michala Fischer-Hansen appointed board member
  • Moved to Kalvebod Brygge 35, 1560 København V
  • Share capital changed from 513,853 DKK to 515,033 DKK
  • Annual report for 2020 published
  • Share capital changed from 509,656 DKK to 513,853 DKK
20206 changesaccounts 1 · management 4 · capital 1
  • Annual report for 2019 published
  • Niels Smedegaard appointed chair of the board
  • Troels Peter Troelsen appointed board member
  • Ole Jensen stepped down as board member
  • Troels Peter Troelsen stepped down as chair of the board
  • Share capital changed from 505,662 DKK to 509,656 DKK
201911 changescapital 2 · management 6 · ownership 3
  • Share capital changed from 377,789 DKK to 505,662 DKK
  • Mark Johnston appointed board member
  • Anders Kunze Bønding appointed board member
  • Jens Albert Harsaae appointed board member
  • CHR. AUGUSTINUS FABRIKKER AKTIESELSKAB registered as owner (33.33%)
  • Wagner Family Holding ApS registered as owner (50%)
  • Anders Kunze Bønding stepped down as deputy chair
  • Jens Albert Harsaae stepped down as deputy chair
  • Wagner Family Holding ApS is no longer registered as owner
  • Share capital changed from 372,500 EUR to 377,789 DKK
  • Anders Kunze Bønding appointed deputy chair
20183 changescapital 1 · management 2
  • Share capital changed from 2,774,747 DKK to 372,500 EUR
  • Jens Albert Harsaae appointed deputy chair
  • Jens Albert Harsaae stepped down as board member
20176 changesmanagement 5 · capital 1
  • Bo Michael Palm stepped down as board member
  • Share capital changed from 2,642,617 DKK to 2,774,747 DKK
  • Jens Albert Harsaae appointed board member
  • Bo Michael Palm appointed board member
  • Iwan Alstrup stepped down as board member
  • John Wagner stepped down as board member
20163 changesownership 3
  • Wagner Family Holding ApS registered as owner (90%)
  • Thorsen Ejendomme A/S is no longer registered as owner
  • Wagner Family Holding ApS is no longer registered as owner
20153 changescapital 1 · ownership 2
  • Share capital changed from 2,128,378 DKK to 2,642,617 DKK
  • Thorsen Ejendomme A/S registered as owner (25%)
  • Thorsen Ejendomme A/S is no longer registered as owner
20145 changesmanagement 3 · capital 1 · ownership 1
  • Ole Jensen appointed board member
  • Iwan Alstrup appointed board member
  • Lars Aaen stepped down as board member
  • Share capital changed from 1,968,750 DKK to 2,128,378 DKK
  • Thorsen Ejendomme A/S registered as owner (5%)
20133 changesmanagement 3
  • Troels Peter Troelsen appointed chair of the board
  • Lars Christian Bruhn stepped down as chair of the board
  • Lars Aaen appointed board member
20124 changesownership 1 · management 2 · industry 1
  • Wagner Family Holding ApS registered as owner (66.67%)
  • Lars Christian Bruhn appointed chair of the board
  • Per Villendrup Jenster stepped down as chair of the board
  • Industry changed to Wholesale of pharmaceutical goods and nursing supplies (464610)
20103 changesname 1 · capital 2
  • Name changed from ABACUS MEDICINE ApS to ABACUS MEDICINE A/S
  • Share capital changed from 140,625 DKK to 1,968,750 DKK
  • Share capital changed from 135,000 DKK to 140,625 DKK
20094 changesmanagement 4
  • Flemming Wagner appointed ceo
  • Flemming Wagner appointed board member
  • Jytte Birgitte Wagner stepped down as board member
  • John Wagner stepped down as director
20081 changeindustry 1
  • Industry changed to Manufacture of pharmaceutical preparations (212000)
20061 changecapital 1
  • Share capital changed from 125,000 DKK to 135,000 DKK
20046 changesindustry 1 · founded 1 · management 4
  • Industry changed to Aluminium production (244200)
  • Registered as ABACUS MEDICINE ApS
  • Per Villendrup Jenster appointed chair of the board
  • Jytte Birgitte Wagner appointed board member
  • John Wagner appointed director
  • John Wagner appointed board member

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 23/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction